2021
DOI: 10.1002/jcla.24111
|View full text |Cite
|
Sign up to set email alerts
|

Measurement of synovium and serum dual specificity phosphatase 22 level: Their inter‐correlation and potency as biomarkers in rheumatoid arthritis

Abstract: Background Dual specificity phosphatase 22 (DUSP22), also named as Jun N‐terminal kinase pathway associated phosphatase recently, is reported to be closely engaged in immune and inflammation regulation. This study aimed to investigate the interaction between synovium DUSP22 and serum DUSP22 levels and to explore their correlation with rheumatoid arthritis (RA) risk, inflammation, and disease activity. Methods Synovium and serum samples from 42 RA patients with knee involvement underwent arthroscopy, and 20 kne… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 30 publications
0
2
0
Order By: Relevance
“…Moreover, DUSP22 gene expression in T cells was negatively correlated with BASDAI, which was a measure of main symptoms experienced by AS patients. Similarly, DUSP22 level in synovium or serum was negatively correlated with CRP level and disease activity score in 28 joints (DAS28-ESR) in patients with RA [ 26 ]. In this report, the longitudinal observations suggest that DUSP22 levels can serve as a good biomarker for treatment response in AS patients.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Moreover, DUSP22 gene expression in T cells was negatively correlated with BASDAI, which was a measure of main symptoms experienced by AS patients. Similarly, DUSP22 level in synovium or serum was negatively correlated with CRP level and disease activity score in 28 joints (DAS28-ESR) in patients with RA [ 26 ]. In this report, the longitudinal observations suggest that DUSP22 levels can serve as a good biomarker for treatment response in AS patients.…”
Section: Discussionmentioning
confidence: 99%
“…DUSP-family phosphatases regulate T cell-mediated immune responses and the production of proinflammatory cytokines, which play crucial roles in the pathogenesis of inflammatory arthritis [ 4 , 5 , 11 , 25 ]. DUSP22 levels in synovium and serum are inversely correlated with inflammation and disease activity in patients with rheumatoid arthritis (RA) [ 26 ]. Moreover, downregulation of DUSP22 protein in T cells is a prognostic biomarker for SLE nephritis [ 12 ].…”
Section: Introductionmentioning
confidence: 99%